Novo Nordisk is expanding access to its drug Wegovy through a new partnership with WeightWatchers, days after cutting ties with telehealth firm Hims & Hers.
Starting July 1, WeightWatchers will collaborate with Humana’s CenterWell Pharmacy to fulfill and deliver prescriptions for Wegovy, with an aim to simplify access to the medication, according to a June 26 news release from the drugmaker.
As part of the new partnership, Novo Nordisk will launch a temporary $299 cash offer price for Wegovy from July 1-31. The offer applies to self-pay patients who are new to the company’s savings program or have not yet filled a prescription through NovoCare Pharmacy.
The move follows Novo Nordisk’s abrupt termination of its partnership with Hims & Hers, alleging the telehealth firm sold knockoff versions of Wegovy and for using deceptive marketing practices.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
